378 related articles for article (PubMed ID: 35744954)
1. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry and glycomics.
Zaia J
OMICS; 2010 Aug; 14(4):401-18. PubMed ID: 20443730
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics protocols in glycomics and glycoproteomics.
Tang H; Mayampurath A; Yu CY; Mechref Y
Curr Protoc Protein Sci; 2014 Apr; 76():2.15.1-2.15.7. PubMed ID: 24692013
[TBL] [Abstract][Full Text] [Related]
5. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
6. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
[TBL] [Abstract][Full Text] [Related]
7. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.
Rosenbalm KE; Tiemeyer M; Wells L; Aoki K; Zhao P
STAR Protoc; 2020 Dec; 1(3):100214. PubMed ID: 33377107
[TBL] [Abstract][Full Text] [Related]
8. Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions.
Khatri K; Klein JA; White MR; Grant OC; Leymarie N; Woods RJ; Hartshorn KL; Zaia J
Mol Cell Proteomics; 2016 Jun; 15(6):1895-912. PubMed ID: 26984886
[TBL] [Abstract][Full Text] [Related]
9. Glycomics and proteomics analyses of mouse uterine luminal fluid revealed a predominance of Lewis Y and X epitopes on specific protein carriers.
Kuo CW; Chen CM; Lee YC; Chu ST; Khoo KH
Mol Cell Proteomics; 2009 Feb; 8(2):325-42. PubMed ID: 18941134
[TBL] [Abstract][Full Text] [Related]
10. A mass spectrometry-based glycotope-centric cellular glycomics is the more fruitful way forward to see the forest for the trees.
Khoo KH
Biochem Soc Trans; 2021 Feb; 49(1):55-69. PubMed ID: 33492355
[TBL] [Abstract][Full Text] [Related]
11. Micro- and macroheterogeneity of N-glycosylation yields size and charge isoforms of human sex hormone binding globulin circulating in serum.
Sumer-Bayraktar Z; Nguyen-Khuong T; Jayo R; Chen DD; Ali S; Packer NH; Thaysen-Andersen M
Proteomics; 2012 Nov; 12(22):3315-27. PubMed ID: 23001782
[TBL] [Abstract][Full Text] [Related]
12. Glycoproteomics: Charting new territory in mass spectrometry and glycobiology.
Malaker SA
J Mass Spectrom; 2024 Jun; 59(6):e5034. PubMed ID: 38726698
[TBL] [Abstract][Full Text] [Related]
13. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
14. Global and site-specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry.
Xiao H; Sun F; Suttapitugsakul S; Wu R
Mass Spectrom Rev; 2019 Aug; 38(4-5):356-379. PubMed ID: 30605224
[TBL] [Abstract][Full Text] [Related]
15. Site-specific N-glycan profiles of α
Mirgorodskaya E; Dransart E; Shafaq-Zadah M; Roderer D; Sihlbom C; Leffler H; Johannes L
Biol Cell; 2022 Jun; 114(6):160-176. PubMed ID: 35304921
[TBL] [Abstract][Full Text] [Related]
16. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
[TBL] [Abstract][Full Text] [Related]
18. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
19. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
Schumacher KN; Dodds ED
Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
[TBL] [Abstract][Full Text] [Related]
20. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
Gaunitz S; Tjernberg LO; Schedin-Weiss S
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
